carvedilol has been researched along with fibrinogen in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (75.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bellini, MA; Boschi, L; Forconi, S; Guerrini, M; Pallassini, A; Postorino, G; Richichi, MG; Trabalzini, L; Turchetti, V | 1 |
| Blann, AD; Chin, BS; Gibbs, CR; Lip, GY | 1 |
| Arapogianni, AN; Aznaouridis, KA; Cokkinos, DV; Karpanou, EA; Marinakis, AG; Stefanadis, CI; Vyssoulis, GP | 1 |
| Aksoy, F; Dogan, A; Erdogan, D; Karabacak, M; Karabacak, P; Ozaydin, M | 1 |
1 trial(s) available for carvedilol and fibrinogen
| Article | Year |
|---|---|
Both carvedilol and nebivolol may improve platelet function and prothrombotic state in patients with nonischemic heart failure.
Topics: Adrenergic beta-1 Receptor Antagonists; Benzopyrans; Carbazoles; Carvedilol; Drug Therapy, Combination; Ethanolamines; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Heart Failure; Humans; Male; Mean Platelet Volume; Middle Aged; Nebivolol; Propanolamines; Single-Blind Method | 2014 |
3 other study(ies) available for carvedilol and fibrinogen
| Article | Year |
|---|---|
Haemorheological and endothelial-dependent alterations in heart failure after ACE inhibitor, calcium antagonist and beta blocker.
Topics: Adrenergic beta-Antagonists; Aged; Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Arginine; Blood Viscosity; Calcium; Carbazoles; Carvedilol; Citrulline; Erythrocytes; Female; Fibrinogen; Heart Failure; Humans; Male; Middle Aged; Nitric Oxide Synthase; Propanolamines; Ramipril; Time Factors; Treatment Outcome; Vascular Cell Adhesion Molecule-1; Vasodilator Agents | 2002 |
Neither carvedilol nor bisoprolol in maximally tolerated doses has any specific advantage in lowering chronic heart failure oxidant stress: implications for beta-blocker selection.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Aged, 80 and over; Biomarkers; Bisoprolol; Carbazoles; Carvedilol; Female; Fibrinogen; Heart Failure; Humans; Lipid Peroxides; Male; Middle Aged; Oxidative Stress; P-Selectin; Propanolamines; Statistics, Nonparametric; Treatment Failure; Vasodilator Agents; von Willebrand Factor | 2003 |
The impact of third-generation beta-blocker antihypertensive treatment on endothelial function and the prothrombotic state: effects of smoking.
Topics: Adrenergic beta-Antagonists; Antihypertensive Agents; Benzopyrans; Biomarkers; Blood Pressure; Carbazoles; Carvedilol; Celiprolol; Endothelium, Vascular; Ethanolamines; Female; Fibrinogen; Homocystine; Humans; Hypertension; Male; Middle Aged; Nebivolol; Plasminogen Activator Inhibitor 1; Propanolamines; Smoking; Treatment Outcome; Vasodilation | 2004 |